PaxMedica, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2018-01-01
- Employees
- 7
- Market Cap
- $1.7M
- Website
- http://www.paxmedica.com
A Retrospective Analysis of Suramin Treatment for Stage 1 TBR
Completed
- Conditions
- First Posted Date
- 2023-09-29
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Paxmedica
- Target Recruit Count
- 345
- Registration Number
- NCT06060600
- Locations
- 🇺🇸
PaxMedica, Tarrytown, New York, United States
Double Blind Trial in Children With Autism Spectrum Disorder
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Paxmedica
- Target Recruit Count
- 52
- Registration Number
- NCT06058962
- Locations
- 🇺🇸
PaxMedica, Tarrytown, New York, United States
© Copyright 2024. All Rights Reserved by MedPath